Cryoport, Inc. announced the appointment of Robert Hariri, MD, PhD to its Board of Directors. Dr. Hariri is the Chairman, Founder and Chief Scientific Officer of Celgene Cellular Therapeutics. He has pioneered the use of stem cells and biomaterials to treat a range of life threatening diseases and has made transformative contributions in the field of tissue engineering.

Dr. Hariri is a visionary scientist, surgeon, aviator and entrepreneur. He has over 100 issued and pending patents; authored over 100 published chapters, articles and abstracts; and is most recognized for his discovery of pluripotent stem cells from the placenta and as a member of the team which discovered the physiological activities of TNF (tumor necrosis factor). Along with J. Craig Venter, PhD, Dr. Hariri, is Co-Founder & President of Human Longevity Cellular Therapeutics, Inc. He is Founder and Chairman of Myos Corporation.